Korea S.E.
18:00:00 2024-05-13 EDT
5-day change
1st Jan Change
6,500
KRW
-0.31%
+0.78%
-7.14%
Genoray Co., Ltd. acquired Ultra MEDIKAL CIHAZLAR SANAYI VE TICARET ANONIM SIRKETI.
Genoray Co., Ltd. (KOSDAQ:A122310) acquired Ultra MEDIKAL CIHAZLAR SANAYI VE TICARET ANONIM SIRKETI on February 13, 2023. Bagzibagli Erdem & Sahin acted as legal advisor to Genoray Co.
Genoray Co., Ltd. announces an Equity Buyback for KRW 4,000 million worth of its shares.
04-18
CI
Genoray Co., Ltd. authorizes a Buyback Plan.
04-18
CI
Tranche Update on Genoray Co., Ltd.'s Equity Buyback Plan announced on December 13, 2022.
23-06-11
CI
Tranche Update on Genoray Co., Ltd.'s Equity Buyback Plan announced on December 13, 2022.
23-06-11
CI
Genoray Co., Ltd.'s Equity Buyback announced on December 13, 2022, has expired with 320,111 shares, representing 2.29% for KRW 2,598.88 million.
23-06-11
CI
Genoray Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-11
CI
Tranche Update on Genoray Co., Ltd.'s Equity Buyback Plan announced on December 13, 2022.
23-03-16
CI
Genoray Co., Ltd. acquired Ultra MEDIKAL CIHAZLAR SANAYI VE TICARET ANONIM SIRKETI.
23-02-12
CI
Tranche Update on Genoray Co., Ltd.'s Equity Buyback Plan announced on December 27, 2021.
22-12-27
CI
Tranche Update on Genoray Co., Ltd.'s Equity Buyback Plan announced on December 27, 2021.
22-12-27
CI
Tranche Update on Genoray Co., Ltd.'s Equity Buyback Plan announced on December 27, 2021.
22-12-27
CI
Tranche Update on Genoray Co., Ltd.'s Equity Buyback Plan announced on December 27, 2021.
22-12-27
CI
Genoray Co., Ltd.'s Equity Buyback announced on December 27, 2021, has expired with 317,000 shares, representing 2.23% for KRW 2,982.1 million.
22-12-26
CI
Genoray Co., Ltd. announces an Equity Buyback for KRW 6,000 million worth of its shares.
22-12-12
CI
Genoray Co., Ltd. authorizes a Buyback Plan.
22-12-12
CI
Genoray Co., Ltd.'s Equity Buyback Plan Extended till December 27, 2022.
22-06-23
CI
Tranche Update on Genoray Co., Ltd.'s Equity Buyback Plan announced on December 27, 2021.
22-03-29
CI
Genoray Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.
21-12-26
CI
Genoray Co., Ltd. authorizes a Buyback Plan.
21-12-26
CI
Genoray Co., Ltd.'s Equity Buyback announced on August 8, 2019, has expired.
20-08-09
CI
Genoray Co., Ltd.'s Equity Buyback Plan Extended till August 10, 2020.
20-02-04
CI
Genoray Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.
19-08-07
CI
Genoray Co., Ltd. authorizes a Buyback Plan.
19-08-07
CI
Genoray Co., Ltd. has completed an IPO in the amount of KRW 13.844666 billion.
18-05-23
CI
Genoray Co., Ltd. has filed an IPO.
17-10-12
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
GENORAY CO., LTD is a Korea-based company that manufactures and sells hospital and dental X-ray imaging diagnostic equipments. The Company operates its business through two segments. The Medical segment manufactures and sells mobile C-arm and mammography equipments. The Dental segment manufactures and sells panoramic equipment, cephalometry equipment, 3D computed tomography (CT), portable X-ray equipment.
More about the company
1st Jan change
Capi.
-7.14% 65.05M -0.97% 15.37B -36.20% 2.92B -12.03% 2.48B -12.41% 1.45B -.--% 1.12B +65.31% 609M +89.23% 499M +16.06% 249M -2.35% 225M
Medical Imaging Systems
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
GENORAY CO., LTD. 